Assessment of the presence of bioaerosols in a neonatal intensive care unit ; Evaluación de la presencia de bioaerosoles en una unidad de cuidados intensivos neonatales

Corporación Universidad de la Costa

2019

REDICUC - Repositorio Universidad de La Costa

application/pdf

[1] E. Jara and J. Piraquive, “Determinación de la calidad de aire intrmural en la Clínica Veterinaria, Universidad de la Salle,” Universidad de la Salle, Bogotá, 2016.; [2] M. Hernandez and S. León, “Determinación de la calidad del aire extramural e intramural en la sala de cirugía del hospital el tunal de la cuidad de Bogotá para el desarrollo de mecanismos de control y minimización de riesgo causado por microorganismos potencialmente nosocomiales,” 2008.; [3] M. Solé and J. Obiols, “NTP 288 : Síndrome del edificio enfermo : enfermedades relacionadas y papel de los bioaerosoles,” Inst. Nac. Segur. e Hig. en el Trab., pp. 1–10, 2005.; [4] C. Avila Figueroa, M. Medina-mejía, and I. Hernándezramos, “Infecciones nosocomiales en una unidad de cuidados intensivos neonatales,” Perinatol Reprod Hum, vol. 14, no. 14, pp. 143–150, 2000.; [5] G. Edith and C. Espinoza, “Determinación de organismos mesófilos aerobios en el ambiente de Cd . Obregón , Sonora; mediante el uso del monitor aéreo microbiológico y método de cuenta en placa abierta,” 2005.; [6] M. J. Pelczar, E. C. . Chan, and N. R. Krieg, “Microbiology. 5th ed,” Tata Mc Graw Hill Publ., 1993.; [7] J. Gutiérrez, E. Romero, L. Reyes, A. Samdoval, and C. Aguirre, “Bioaerosoles depositados vía húmeda-seca en la zona metropolitana del valle de toluca,” Contancto Nucl., pp. 16–23, 2009.; [8] F. Abdel-Wahab, M. Ghoneim, M. Khashaba, A.-H. ElGilany, and D. Abdel-Hady, “Nosocomial infection surveillance in an Egyptian neonatal intensive care unit.,” J. Hosp. Infect., vol. 83, no. 3, pp. 196–199, 2013.; [9] A. A. Jaffal, H. Nsanze, A. Bener, A. S. Ameen, I. M. Banat, and A. A. El Mogheth, “Hospital airborne microbial pollution in a desert country,” Environ. Int., vol. 23, no. 2, pp. 167–172, 1997.; [10] K. Youn, Y. Shin, and Daekeun, “Distribution characteristics of airborne bacteria and fungi in the general hospitals of Korea.,” Ind. Health, vol. 48, no. 2, pp. 236–243, 2010.; [11] W. Coronell, J. Rojas, M. Escamilla, M. Manotas, and M. Sánchez, “Infección Nosocomial En Unidades de Cuidados Intensivos Neonatales,” Precop SCP, vol. 9, no. 3, pp. 30–39, 2010.; [12] M. Leung and A. H. S. Chan, “Control and management of hospital indoor air quality.,” Med. Sci. Monit., vol. 12, no. 3, pp. SR17-R23, 2006.; [13] W. Wang et al., “Diversity and seasonal dynamics of airborne bacteria in the Mogao Grottoes, Dunhuang, China,” Aerobiologia (Bologna)., vol. 28, no. 1, pp. 27– 38, 2012.; [14] C. Carvajal, “Evaluación del comportamiento de aerobacterias en el corregimiento de Cuatro,” 2016.; [15] S. S. Ortiz J, Prendez M, “Utilizacion y manejo de un impactador de cascada ANDERSEN en el estudio de los aerosoles atmosfericos.” Universidad de Tarapaca, Chile, Tarapaca, pp. 8–8, 1986.; [16] Y. Heo, J. Park, S. Lim, H. Hur, D. Kim, and K. Park, “Size-resolved culturable airborne bacteria sampled in rice field, sanitary landfill, and waste incineration sites,” J. Environ. Monit., vol. 12, no. 8, p. 1619, 2010.; [17] C. S. Li and P. A. Hou, “Bioaerosol characteristics in hospital clean rooms,” Sci. Total Environ., vol. 305, no. 1–3, pp. 169–176, 2003.; [18] H. Zhu, P. Phelan, T. Duan, G. Raupp, and H. J. S. Fernando, “Characterizations and relationships between outdoor and indoor bioaerosols in an office building,” China Particuology, vol. 1, no. 3, pp. 119– 123, 2003.; [19] M. del C. Martí Solé, “Método para el recuento de bacterias y hongos en aire,” Inst. Nac. Segur. e Hig. en el Trab., vol. 3, pp. 1–4, 1991.; [20] A. Pinheiro, “MICROBIOTA FÚNGICA DO AMBIENTE DA UTI NEONATAL E DE AMOSTRAS CLÍNICAS DOS RECÉM-NASCIDOS INTERNADOS NO HOSPITAL UNIVERSITÁRIO DE MACEIÓ, AL,” UNIVERSIDADE FEDERAL DE ALAGOAS-UFAL, 2009.; [21] C. Viegas et al., “Fungal burden in waste industry: an occupational risk to be solved,” Environ. Monit. Assess., vol. 187, no. 4, 2015.; [22] C. He et al., “Particle and bioaerosol characteristics in a paediatric intensive care unit,” Environ. Int., vol. 107, no. June, pp. 89–99, 2017.; [23] MACHER and J., “Sampling airborne microorganisms and aeroallergens,” Air Sampl. Instruments Eval. Atmos. Contam., pp. 589–617, 1995.; [24] N. Yamamoto, D. Schmechel, B. T. Chen, W. G. Lindsley, and J. Peccia, “Comparison of quantitative airborne fungi measurements by active and passive sampling methods,” J. Aerosol Sci., vol. 42, no. 8, pp. 499–507, 2011.; [25] M. Sadyś, R. Kennedy, and J. S. West, “Potential impact of climate change on fungal distributions: analysis of 2 years of contrasting weather in the UK,” Aerobiologia (Bologna)., vol. 32, no. 1, pp. 127–137, 2016.; [26] R. S. Dungan, “Board-invited review: Fate and transport of bioaerosols associated with livestock operations and manures,” J. Anim. Sci., vol. 88, no. 11, pp. 3693–3706, 2010.; [27] A. K. Pahari, D. Dasgupta, R. S. Patil, and S. Mukherji, “Emission of bacterial bioaerosols from a composting facility in Maharashtra, India,” Waste Manag., vol. 53, pp. 22–31, 2016.; [28] W. B. Morgado Gamero et al., “Hospital Admission and Risk Assessment Associated to Exposure of Fungal Bioaerosols at a Municipal Landfill Using Statistical Models,” in Intelligent Data Engineering and Automated Learning -- IDEAL 2018, 2018, pp. 210– 218.; [29] W. B. Morgado Gamero, M. C. Ramírez, A. Parody, A. Viloria, M. H. A. López, and S. J. Kamatkar, “Concentrations and Size Distributions of Fungal Bioaerosols in a Municipal Landfill,” in Data Mining and Big Data, 2018, pp. 244–253.; [30] K. Uhrbrand, A. C. Schultz, A. J. Koivisto, U. Nielsen, and A. M. Madsen, “Assessment of airborne bacteria and noroviruses in air emission from a new highlyadvanced hospital wastewater treatment plant,” Water Res., vol. 112, pp. 110–119, 2017.; [31] C. Alonso, P. C. Raynor, P. R. Davies, and M. Torremorell, “Concentration, size distribution, and infectivity of airborne particles carrying swine viruses,” PLoS One, vol. 10, no. 8, 2015.; [32] A. H. Awad, Y. Saeed, Y. Hassan, Y. Fawzy, and M. Osman, “Air microbial quality in certain public buildings, Egypt: A comparative study,” Atmospheric Pollution Research, 2018.; [33] J. S. Pastuszka, U. Kyaw Tha Paw, D. O. Lis, A. Wlazło, and K. Ulfig, “Bacterial and fungal aerosol in indoor environment in Upper Silesia, Poland,” Atmos. Environ., vol. 34, no. 22, pp. 3833–3842, 2000.; [34] R. I. Adams, M. Miletto, S. E. Lindow, J. W. Taylor, and T. D. Bruns, “Airborne bacterial communities in residences: Similarities and differences with fungi,” PLoS One, vol. 9, no. 3, 2014.; [35] B. Ghosh, H. Lal, and A. Srivastava, “Review of bioaerosols in indoor environment with special reference to sampling, analysis and control mechanisms,” Environ. Int., vol. 85, pp. 254–272, 2015.; [36] A. J. Prussin and L. C. Marr, “Sources of airborne microorganisms in the built environment,” Microbiome, vol. 3, p. 78, 2015.; [37] K. Wai Tham, “Indoor air quality and its effects on humans—A review of challenges and developments in the last 30 years,” Energy Build., vol. 130, pp. 637–650, 2016.; [38] J. Berenguer and J. L. Sanz, Cuestiones en microbiología. Editorial Hélice, 2004.; [39] S. Cabo Verde et al., “Microbiological assessment of indoor air quality at different hospital sites,” Res. Microbiol., vol. 166, no. 7, pp. 557–563, 2015.; [40] M. Maldonado, J. Peña, S. De los Santos, A. Castellanos, D. Camarena, and B. Arévalo, “BIOAEROSOLES Y EVALUACIÓN DE LA CALIDAD DEL AIRE EN DOS CENTROS Laura VALDÉS-SANTIAGO , Laura J . HERNÁNDEZVALADEZ y Dora Linda GUZMÁN DE PEÑA * biopartículas INTRODUCCIÓN Los bioaerosoles o biopartículas pueden definir - se como partículas o microfragme,” vol. 30, no. 4, pp. 351–363, 2014.; [41] SAMPSP, “Recomendaciones para la monitorización de la calidad microbiológica del aire (bioseguridad ambiental) en zonas hospitalarias de riesgo.,” pp. 1–35, 2016.; [42] K. H. Kim, E. Kabir, and S. A. Jahan, “Airborne bioaerosols and their impact on human health,” J. Environ. Sci. (China), vol. 67, pp. 23–35, 2018.; [43] C. Y. Rao, H. A. Burge, and J. C. Chang, “Review of quantitative standards and guidelines for fungi in indoor air.,” J. Air Waste Manag. Assoc., vol. 46, no. 9, pp. 899–908, Sep. 1996.; [44] IAQA (Indoor Air Quality Association)., “Indoor Air Quality Standard #95-1 Recommended for Florida,” Longwood, Florida, 1995.; [45] H. Heida, F. Bartman, and S. C. van der Zee, “Occupational Exposure and Indoor Air Quality Monitoring in a Composting Facility,” Am. Ind. Hyg. Assoc. J., vol. 56, no. 1, pp. 39–43, Jan. 1995.; [46] OSHA - Occupational Safety and Health Administration., Indoor air quality. Canada, 1994, pp. 15968–16039.; [47] K. Y. Kim and C. N. Kim, “Airborne microbiological characteristics in public buildings of Korea,” Build. Environ., vol. 42, no. 5, pp. 2188–2196, 2007.; [48] Y. Zhang et al., “Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo,” J. Infect. Chemother., vol. 21, no. 11, pp. 808– 815, 2015.; [49] K. Hardjawinata, R. Setiawati, and W. Dewi, “Bactericidal efficacy of ultraviolet irradiation on Staphylococcus aureus,” Asian J. Oral Maxillofac. Surg., vol. 17, no. 3, pp. 157–161, 2005.; [50] K. M. Sohn, J. Y. Baek, S. H. Kim, S. Cheon, and Y. S. Kim, “Catheter-related bacteremia caused by kocuria salsicia: The first case,” J. Infect. Chemother., vol. 21, no. 4, pp. 305–307, 2015.; [51] A. Uekotter, J. Konig, G. Peters, and K. Becker, Portinfection due to Kocuria rhizophila in an 8 year old child with methylmalonic aciduria. 2006.; [52] M. Gholami, Z. Etemadifar, and M. Bouzari, “Isolation a new strain of Kocuria rosea capable of tolerating extreme conditions,” J. Environ. Radioact., vol. 144, pp. 113–119, 2015.; [53] M. De La Rosa, M. . Mosso, and C. Ullán, “El aire: hábitat y medio de transmisión de microorganismos,” Obs. Medioambient., vol. 5, pp. 375–402, 2002.; [54] B. Martinez, R. Ruiz, and R. Perez, “[What are we learning about Staphylococcus saprophyticus?],” Enferm. Infecc. Microbiol. Clin., vol. 26, no. 8, pp. 495–499, 2008.; [55] W. Ziebuhr, S. Hennig, M. Eckart, H. Kränzler, C. Batzilla, and S. Kozitskaya, “Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen,” Int. J. Antimicrob. Agents, vol. 28, no. SUPPL. 1, pp. 14–20, 2006.; [56] Y. Dong and C. P. Speer, “The role of Staphylococcus epidermidis in neonatal sepsis: Guarding angel or pathogenic devil?,” International Journal of Medical Microbiology, vol. 304, no. 5–6. pp. 513–520, 2014.; [57] K. A. Thompson, A. M. Bennett, and J. T. Walker, “Aerosol survival of Staphylococcus epidermidis,” J. Hosp. Infect., vol. 78, no. 3, pp. 216–220, 2011.; [58] S. Borrego, I. Perdomo, J. De La Paz, S. Gómez De Saravia, and P. Guiamet, “Relevamiento microbiológico del aire y de materiales almacenados en el Archivo Histórico del Museo de La Plata, Argentina y en el Archivo Nacional de la República de Cuba,” Rev. del Mus. La Plata, vol. 18, no. 119, pp. 1–18, 2011.; [59] M. Macedo and J. Blanco, “Infecciones hospitalarias,” Control, pp. 245–254, 2008.; [60] B. Orden-Martínez, R. Martínez-Ruiz, and R. MillánPérez, “¿Qué estamos aprendiendo de Staphylococcus saprophyticus?,” Enferm. Infecc. Microbiol. Clin., vol. 26, no. 8, pp. 495–499, 2008.; [61] S. Estrada, M. Restrepo, E. Jaramillo, and C. M. Montoya, “Staphylococcus saprophyticus como agente etiológico de la infección del tracto urinario,” Acta médica Colomb., vol. 15, no. 5, pp. 292–297, 1990.; [62] J. Soldera, W. L. Nedel, P. R. Cardoso, and P. A. d’Azevedo, “Bacteremia due to Staphylococcus cohnii ssp. urealyticus caused by infected pressure ulcer: case report and review of the literature,” Sao Paulo Med.J., vol. 131, no. 1806-9460 (Electronic), pp. 59–61, 2013.; [63] S. Mendoza et al., “Draft genome sequences of two opportunistic pathogenic strains of Staphylococcus cohnii isolated from human patients,” Stand. Genomic Sci., vol. 12, no. 1, 2017.; [64] Z. Shahandeh, H. Shafi, and F. Sadighian, “Association of staphylococcus cohnii subspecies urealyticum infection with recurrence of renal staghorn stone,” J. Intern. Med., vol. 6, no. 1, pp. 40–42, 2015.; [65] M. Paul, R. Gupta, S. Khush, and R. Thakur, “Kocuria rosea : An emerging pathogen in acute bacterial meningitis- Case report,” J. Microbiol. Antimicrob. Agents, vol. 1, no. 1, pp. 4–7, 2015.; [66] J. S. Moreira, A. G. L. Riccetto, M. T. N. da Silva, and M. M. dos S. Vilela, “Endocarditis by Kocuria rosea in an immunocompetent child,” Brazilian J. Infect. Dis., vol. 19, no. 1, pp. 82–84, 2015.; [67] M. Corti, M. F. Villafañe, I. Soto, O. Palmieri, and R. Callejo, “Bacteriemia por Kocuria rosea en un paciente con SIDA,” Rev. Chil. infectología, vol. 29, no. 3, pp. 355–356, 2012.; [68] N. J. Hilliard, R. L. Schelonka, and K. B. Waites, “Bacillus cereus bacteremia in a preterm neonate,” J. Clin. Microbiol., vol. 41, no. 7, pp. 3441–3444, 2003.; [69] C. Machado, A. Silva, M. J. Magalhães, C. Sá, and E. Abreu, “Severe Bacillus cereus infection in a neonatal intensive care unit,” Case Rep. Perinat. Med, vol. 3, no. 2, pp. 159–162, 2014.; [70] S. Puvabanditsin, A. Zaafran, E. Garrow, R. Diwan, D. Mehta, and N. Phattraprayoon, “Bacillus cereus meningoencephalitis in a neonate,” Hong Kong J. Paediatr., vol. 12, no. 4, pp. 293–296, 2007.; [71] V. M. Shivamurthy, S. Gantt, C. Reilly, P. Tilley, J. Guzman, and L. Tucker, “Bacillus pumilus Septic Arthritis in a Healthy Child,” Can. J. Infect. Dis. Med. Microbiol., 2016.; [72] Y. Yuan and M. Gao, “Genomic analysis of a ginger pathogen Bacillus pumilus providing the understanding to the pathogenesis and the novel control strategy,” Sci. Rep., vol. 5, 2015.; [73] M. Kimouli et al., “Two cases of severe sepsis caused by Bacillus pumilus in neonatal infants,” J. Med. Microbiol., vol. 61, no. 4, pp. 596–599, 2012.; [74] F. Celandroni et al., “Identification and pathogenic potential of clinical Bacillus and Paenibacillus isolates,” PLoS One, vol. 11, no. 3, 2016.; [75] R. Camacho et al., “Characterization of Cry toxins from autochthonous Bacillus thuringiensis isolates from Mexico,” Bol. Med. Hosp. Infant. Mex., vol. 74, no. 3, pp. 193–199, 2017.; [76] M. R. Oggioni, G. Pozzi, P. E. Valensin, P. Galieni, and C. Bigazzi, “Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.,” J. Clin. Microbiol., vol. 36, no. 1, pp. 325–6, 1998.; [77] A. F. Sheikh et al., “Identification of Alloiococcus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in children with otitis media with effusion,” Jundishapur J. Microbiol., vol. 8, no. 3, 2015.; [78] K. Tano, R. Von Essen, P. O. Eriksson, and A. Sjöstedt, “Alloiococcus otitidis - Otitis media pathogen or normal bacterial flora?,” APMIS, vol. 116, no. 9, pp. 785–790, 2008.; [79] A. Harimaya, R. Takada, Y. Somekawa, N. Fujii, and T. Himi, “High frequency of Alloiococcus otitidis in the nasopharynx and in the middle ear cavity of otitisprone children,” Int. J. Pediatr. Otorhinolaryngol., vol. 70, no. 6, pp. 1009–1014, 2006.; [80] J. E. Hage, P. E. Schoch, and B. A. Cunha, “Pseudomonas pseudoalcaligenes peritoneal dialysisassociated peritonitis,” Perit. Dial. Int., vol. 33, no. 2, pp. 223–224, 2013.; [81] J. Potorski, I. Koniuszewska, M. Czatzkowska, and M. Harnisz, “Drug resistance in airborne bacteria isolated from waste management and wastewater treatment plants in Olsztyn,” vol. 66, pp. 1–8, 2019.; [82] S. United, S. Environmental, and S. California, “Continuous and Semicontinuous Monitoring Techniques for Particulate Matter Mass and Chemical Components : A Synthesis of Findings from EPA ’ s Particulate Matter Supersites Program an . Continuous and Semicontinuous Monitoring Techniques for Particulate,” no. May 2016, 2008.; [83] R. N. Jones, “Microbial Etiologies of Hospital Acquired Bacterial Pneumonia and Ventilator Associated Bacterial Pneumonia,” Clin. Infect. Dis., vol. 51, no. S1, pp. S81–S87, 2010.; [84] U. Valle and U. Valle, “La resistencia de bacterias a antibióticos , antisépticos y desinfectantes una manifestación de los mecanismos de supervivencia y adaptación,” 2007.; [85] Secretaría Distrital de Salud de Bogotá, “Boletín epidemiológico de resistencia bacteriana – SIVIBAC año 2007,” Grup. para el Control la Resist. Bact. Bogotá, 2009.; [86] A. Patricia, L. Isabel, S. Milena, and M. Victoria, “Vigilancia de infecciones asociadas a la atención en salud , resistencia bacteriana y consumo de antibióticos en hospitales de alta complejidad , Colombia , 2011,” 2014.; [87] A. Hoyos Orrego, O. Rivera Rivera, C. Hoyos Posada, C. Mesa Restrepo, and V. Alfaro., “Características clínicas, epidemiológicas y de susceptibilidad a los antibióticos en casos de bacteriemia por Klebsiella pneumoniae en neonatos,” CES, vol. 21, pp. 31–39, 2007.; [88] GREBO, “S ECRETARIA MANUAL DE ACTUALIZACION EN RESISTENCIA BACTERIANA Y NORMAS CLSI M100 – S20,” Secr. salud, pp. 1–78, 2010.; https://hdl.handle.net/11323/7373; https://doi.org/10.1109/CASAP.2019.8916742; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.co/

10.1109/CASAP.2019.8916742

Attribution-NonCommercial-NoDerivatives 4.0 International ; http://creativecommons.org/licenses/by-nc-nd/4.0/ ; info:eu-repo/semantics/openAccess ; http://purl.org/coar/access_right/c_abf2

edsbas.5ADEB388